Data Foundry

Drug recalls 2021

LOTRIMIN AF — Class II drug recall D-0240-2022

Terminated recall by Bayer Healthcare Pharmaceuticals Inc., reported 2021-11-24, distributed nationwide. cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene

Recall numberD-0240-2022
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmBayer Healthcare Pharmaceuticals Inc., Whippany, NJ, United States
Recall initiated2021-10-01
Classified2021-11-18
Reported by FDA2021-11-24
Terminated2023-06-26
DistributedNationwide (US)
Countries outside the USCA, MX
Quantity579,456 cans
Reason classeschemical contamination, cgmp
UPC / GTIN / UDI-DI00041100587206, 00041100589613
NDC11523-0010, 11523-0010-01, 11523-0010-02
Lot numbersTN0023DAV, TN0023DBV, TN0023DC, TN0023DV, TN003C7, TN0056Z, TN00570, TN005KJ, TN005KJA, TN005KJB
Expiration dates2022-01-31, 2022-02-28, 2022-04-30, 2022-07-31, 2022-08-31

Product

LOTRIMIN AF (Tolnaftate 1%) DAILY PREVENTION deodorant powder spray, NET WT 160g (5.6 OZ) can, packaged as (a) single pack, UPC 0 41100 58720 6, NDC 11523-0010-2; (b) 3-pack, UPC 0 41100 58961 3; Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Finland,

Reason for recall

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0240-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.